Current and former FDA heads and international coalition leaders called for regulatory alignment across the globe on COVID-19 vaccine supply and distribution in order to help global public health leaders ensure equitable access. At the same time, FDA biologics center director Peter Marks tried to dampen concerns that the first country to get a vaccine will prioritize distribution among its own population and block access to the rest of the world, likening the situation to putting on an oxygen mask...